Common Contracts
4 similar Option Award Agreement contracts by ProPhase Labs, Inc.
PROPHASE LABS, INC. OPTION AWARD AGREEMENTOption Award Agreement • March 29th, 2024 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the ____th day of _______ (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and _____________ (hereinafter called the “Participant”):
PROPHASE LABS, INC. OPTION AWARD AGREEMENTOption Award Agreement • March 29th, 2023 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the ____th day of _______ (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and _____________ (hereinafter called the “Participant”):
PROPHASE LABS, INC. AMENDED AND RESTATED 2010 EQUITY COMPENSATION PLAN OPTION AWARD AGREEMENTOption Award Agreement • August 20th, 2018 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the [DAY] day of [MONTH], [YEAR], (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and [NAME] (hereinafter called the “Participant”):
PROPHASE LABS, INC. AMENDED AND RESTATED 2010 EQUITY COMPENSATION PLAN OPTION AWARD AGREEMENTOption Award Agreement • May 15th, 2017 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT (the “Agreement”), is made effective as of the [DAY] day of [MONTH], [YEAR], (hereinafter called the “Date of Grant”), between ProPhase Labs, Inc., a Delaware corporation (hereinafter called the “Company”), and [NAME] (hereinafter called the “Participant”):
